Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

3

Clinical Outcomes after Discontinuation of Lamivudine in Chronic Hepatitis B Patients with Lamivudine Resistant HBV Mutant

Jeong Ki Kim, M.D. Seong Gyu Hwang, M.D. Hyeuk Park, M.D. Hong Youp Choi, M.D. Hyo Jin Cho, B.S. Kwang Hyun Ko, M.D. Sung Pyo Hong, M.D. Pil Won Park, M.D. Nam Keun Kim, Ph.D. and Kyu Sung Rim, M.D.

Clin Mol Hepatol. 2005;11(3):227-242. Published online January 1, 1970

View: 3302 Download: 14

2

Treatment of Chronic Hepatitis B ; The Efficacy of Lamivudine in Korean Patients with Chronic Hepatitis B

Jong Young Choi

Clin Mol Hepatol. 2005;11(1):25-30. Published online January 1, 2000

View: 2655 Download: 12

3

Pretreatment ALT Level and Histologic Activity as Predictors of HBeAg Loss in Lamivudine Treatment for Chronic Hepatitis B

Young Oh Kweon, M.D. and Kyung Hee Kang, M.D.

Clin Mol Hepatol. 2004;10(1):31-41. Published online January 1, 1970

View: 2867 Download: 14

2

Therapeutic Strategy for YMDD Mutants of Hepatitis B Virus

Soo Hyung Ryu, M.D. and Young-Hwa Chung, M.D.

Clin Mol Hepatol. 2004;10(1):1-10. Published online January 1, 1970

View: 2805 Download: 17

3

Clinical and Virologic Characteristics of Lamivudine Resistance in HBV-associated Chronic Liver Disease

Sun Suk Kim, M.D., Moon Gi Chung, M.D., Ki Tak Ju, M.D., Dong Kyun Park, M.D. Oh Sang Kwon, M.D.,Yang Suh Koo, M.D., Yu Kyung Kim, M.D., Duck Ju Choi, M.D. Yu Jin Hwang, Ph.D.* and Ju Hyun Kim, M.D.

Clin Mol Hepatol. 2002;8(4):405-417. Published online January 1, 1970

View: 2573 Download: 16

Clinical Outcome in Cases of Viral Breakthrough During Lamivudine Therapy in Chronic Hepatitis B Patients

Soo Hyun Ahn, M.D., Yun Jung Chang, M.D., Seong Nam Oh, M.D., Do Won Choi, M.D., Soo Jung Baek, M.D., Won Seok Jeong, M.D., Chang Won Choi, M.D., Kyoung Oh Kim, M.D., Hyung Joon Yim, M.D., Nam Young Jo, M.D., Jong Jae Bak, M.D., Jae Seon Kim, M.D., Young-Tae Bak, M.D., Myung Seok Lee, M.D.*, Jong Eun Yeon M.D., Kwan Soo Byun, M.D. and Chang Hong Lee, M.D.

Clin Mol Hepatol. 2002;8(4):389-396. Published online January 1, 1970

View: 2572 Download: 17

Lamivudine-Resistance in Patients with Chronic Hepatitis B and/or Cirrhosis and Detection of Mutations in YMDD Motif of Hepatitis B Virus Genome

Sung Ho Kang,Young Min Park,Jong Young Choi,Je Hyun Shin,Tae Wook Park,Si Hyun Bae,Byung Hun Byun,Byung Min Ahn,Chang Don Lee,Sang Bok Cha,Hee Sik Sun,Doo Ho Park,Boo Sung Kim

Clin Mol Hepatol. 2001;7(1):15-33. Published online January 1, 2000

View: 2707 Download: 18

Emergence of YMDD Motif Mutant Hepatitis B Virus during Short-term Lamivudine Therapy

Yong Han Paik,Kwang Hyub Han,Hyo Young Chung,Chae Yoon Chun,Young Myoung Moon

Clin Mol Hepatol. 1999;5(3):173-183. Published online January 1, 2000

View: 4527 Download: 15

Effect and Safety of 12 Week Lamivudine Therapy in Patients with Chronic Hepatitis B

Dong Jin Suh, M.D., Young-Hwa Chung, M.D., Yung Sang Lee, M.D., Min Ho Lee, M.D. and Kwang Hyub Han, M.D.

Clin Mol Hepatol. 1999;5(2):89-96. Published online January 1, 2000

View: 2401 Download: 16

1 |

Viewed By 8733	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7555	MAFLD: How is it different from NAFLD?
Viewed By 5455	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5057	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4580	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 322	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 292	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 203	MAFLD: How is it different from NAFLD?
Cited By 101	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 92	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search